Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Farrell

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Journal of Neurological Surgery. Part B, Skull Base|May 7, 2026
How Expensive is ENT Surgeons' Involvement in Retrosigmoid Craniotomies? A Time-Driven Activity-Based Cost AnalysisDanyal A Quraishi, D Mitchell Self, Steven Glener, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 17, 2021
Glioblastoma with deep supratentorial extension is associated with a worse overall survivalAdam Barsouk, Michael P Baldassari, Omaditya Khanna, et al.
World Neurosurgery|April 24, 2017
Clinical Outcome After Extended Endoscopic Endonasal Resection of Craniopharyngiomas: Two-Institution ExperienceHye Ran Park, Varun R Kshettry, Christopher J Farrell, et al.
Cancer Research|April 9, 2009
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsHiroaki Wakimoto, Santosh Kesari, Christopher J Farrell, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
World Neurosurgery|May 8, 2024
Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with CraniopharyngiomaSpencer J Poiset, Andrew Song, Hong In Yoon, et al.
Neurosurgery|August 19, 2021
Postoperative Oral Antibiotics and Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Tumors Study: A Multicenter, Prospective, Randomized, Double-Blinded, Placebo-Controlled StudyAndrew S Little, Varun R Kshettry, Marc R Rosen, et al.
The Laryngoscope|July 1, 2021
Assessment of the Validity of the Sinonasal Outcomes Test-22 in Pituitary Surgery: A Multicenter Prospective TrialChristina E Sarris, Andrew S Little, Varun R Kshettry, et al.
Journal of Neuro-Oncology|March 10, 2025
Introducing the operative value index for glioma surgery: an integration of quality-adjusted life years with time-driven activity-based costingAdvith Sarikonda, Danyal Quraishi, D Mitchell Self, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Neurological Surgery. Part B, Skull Base|May 7, 2026
How Expensive is ENT Surgeons' Involvement in Retrosigmoid Craniotomies? A Time-Driven Activity-Based Cost AnalysisDanyal A Quraishi, D Mitchell Self, Steven Glener, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 17, 2021
Glioblastoma with deep supratentorial extension is associated with a worse overall survivalAdam Barsouk, Michael P Baldassari, Omaditya Khanna, et al.
World Neurosurgery|April 24, 2017
Clinical Outcome After Extended Endoscopic Endonasal Resection of Craniopharyngiomas: Two-Institution ExperienceHye Ran Park, Varun R Kshettry, Christopher J Farrell, et al.
Cancer Research|April 9, 2009
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsHiroaki Wakimoto, Santosh Kesari, Christopher J Farrell, et al.
Journal of Neuro-Oncology|December 14, 2017
Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
Journal of Neuro-Oncology|January 10, 2018
Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatmentWenyin Shi, Erik S Blomain, Joshua Siglin, et al.
World Neurosurgery|May 8, 2024
Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with CraniopharyngiomaSpencer J Poiset, Andrew Song, Hong In Yoon, et al.
Neurosurgery|August 19, 2021
Postoperative Oral Antibiotics and Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Tumors Study: A Multicenter, Prospective, Randomized, Double-Blinded, Placebo-Controlled StudyAndrew S Little, Varun R Kshettry, Marc R Rosen, et al.
The Laryngoscope|July 1, 2021
Assessment of the Validity of the Sinonasal Outcomes Test-22 in Pituitary Surgery: A Multicenter Prospective TrialChristina E Sarris, Andrew S Little, Varun R Kshettry, et al.
Journal of Neuro-Oncology|March 10, 2025
Introducing the operative value index for glioma surgery: an integration of quality-adjusted life years with time-driven activity-based costingAdvith Sarikonda, Danyal Quraishi, D Mitchell Self, et al.
Pageof 8